Telecobalt machines found lying idle for months: CAG
Inordinate delay in undertaking turnkey works resulted in non-installation of telecobalt machines - the new imported machines delivered at Dharmapuri and Tiruvannamalai GMCHs were lying idle for 15 months and 36 months respectively and the machine for Pudukkottai GMCH had reached Chennai Port in November 2021 but was not delivered to the hospital as of June 2024.
In its audit report (compliance audit) for the year ending March 2023 that was tabled in the Assembly, the CAG said that to ensure sufficient treatment facilities for patients diagnosed with cancer, the National Health Mission sanctioned ₹57 crore in three installments (in 2018 and 2019) to the Tamil Nadu Medical Services Corporation (TNMSC) for replacement of telecobalt machines in 10 GMCHs and for establishing four new telecobalt centres with bunkers in four GMCHs. In addition, the State government, in 2017, sanctioned ₹3 crore for purchase of a new cobalt therapy unit to Government Arignar Anna Memorial Cancer Hospital, Karapettai.
The TNMSC placed orders for supply and installation of the machines in 15 medical institutions of which 10 were commissioned and patient treatment commenced between August 2021 and October 2023. In the remaining institutions, machines supplied to four hospitals - Rajiv Gandhi Government General Hospital, GMCHs in Tiruvannamalai, Dharmapuri and Karapettai facility - between February 2021 and March 2023 - were not installed, while the machine for GMCH Pudukottai was not supplied till June 2024.
It also observed that TNMSC had failed in ensuring supply of the Treatment Planning System - an essential part of radiation treatment planning - by the supplier resulting in non-commencement of life-saving treatment for patients in five institutions.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
a day ago
- Time of India
Furnish data on malnutrition in 4 weeks: HC tells MP govt
Bhopal: A division bench of the Madhya Pradesh High Court asked district collectors from across the state to file a status report on the malnutrition situation in their respective districts. The bench, comprising Chief Justice Sanjeev Sachdeva and Justice Vinay Saraf, gave four weeks for this purpose and issued notices to the state govt and the chief secretary in response to a Public Interest Litigation (PIL) moved by a resident of Jabalpur, Deepankar Singh. Singh, in his petition, said that there is an alarming situation in MP regarding malnutrition among its people, but the state govt keeps hiding this terrible state of affairs by 'manipulating' data. He requested the court to ask for a report on malnutrition from the state govt to know the actual state of malnutrition prevalent among the people in MP so that efforts could be made to tackle the menace of malnutrition, particularly among the children. He said that according to the Poshan Tracker-2.0 and National Health Survey report, MP stands second in the country in terms of malnutrition. Attributing this situation to poor implementation of schemes on health and nutrition, he said that weak, underweight, and stunted children are born in the state because of malnutrition. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like You will never turn off your computer again. Undo He further said that CAG, in its report, referred to a massive scam in the transportation and quality of nutritious food, but there was no action on the part of the state govt. The petitioner said that among 66 lakh children in the age group of 0 to 6 years, 10 lakh are malnourished, and 1.36 lakh of them are severely malnourished. The prevalence of anaemia among women is 57%. It was also pointed out during the hearing that Rs 1.80 crore were paid as rent for anganwadi centres in Jabalpur district alone, but only a handful of children visit those centres. After the initial hearing, the court asked all the district collectors from across the state to furnish a report on the status of malnutrition in their respective districts within four weeks. Advocate Amit Singh Sengar and Atul Jain appeared in the case for the petitioner.
The Hindu
2 days ago
- The Hindu
40 products, 3 firms blacklisted in two years by T.N. Medical Services Corporation
In two years, the Tamil Nadu Medical Services Corporation (TNMSC) has blacklisted 40 products - drugs and injections - and three firms primarily for failing to meet quality control norms. According to data from TNMSC, an organisation that was set up to streamline the procurement, storage and distribution of essential drugs for government hospitals, 22 products were blacklisted for quality failures during 2023-2024. During 2024-2025, 26 products were blacklisted, of which 22 were quality-related and four for non-execution of purchase orders. A total of 14 products were blacklisted so far in 2025, all related to quality failures. Firm-wise, TNMSC blacklisted five firms during 2023-2024 (two for non-execution of purchase orders and three on quality grounds. While two firms were blacklisted during 2024-2025, one was blacklisted so far this year on quality grounds. Also Read: Not business as usual: On upholding India's reputation for quality drugs Year Number of blacklisted firms Reasons Number of products blacklisted Reasons 2023-2024 5 2 for non execution of purchase orders; 3 on quality grounds 22 All related to quality failures 2024-2025 2 On quality grounds 26 22 quality related 4 non execution of purchase orders 2025 (till date) 1 On quality grounds 14 All related to quality failures How quality checks are performed Officials of TNMSC said that quality checks on medicines are conducted as per the relevant pharmacopoeia (such as Indian Pharmacopoeia, British Pharmacopoeia, United States Pharmacopoeia) at their entry level at warehouses through NABL (National Accreditation Board for Testing and Calibration Laboratories) accredited empanelled laboratories. In case of any adverse reports from empanelled laboratories, the same drugs are re-tested at government laboratories in the State - laboratories at Teynampet and Guindy. Presently, TNMSC has contracts with 12 laboratories situated all over the country. The top reason for blacklisting products is failure to meet quality standards, an official said. Blacklisting is done for products due to quality failure/non supply and for companies as a whole, for quality failures. According to blacklisting details on TNMSC's website, 'not of standard quality' is the major reason cited for blacklisting a particular drug. 'Purchase orders not executed' and 'substandard quality' are other reasons. In fact, one drug has been blacklisted for the 'presence of an iron piece inside the tablet'. For firms blacklisted from 2024, misbranded drugs is the main reason. Monitoring of warehouses TNMSC's warehouses are monitored through the centralised portal - Drug Distribution Management System - for stock receipt, sampling process, receipt of lab reports, distribution to medical institutions and its fund management. The shelf life expired drugs are disposed through biomedical waste management agencies approved by the T.N. Pollution Control Board once in a year, officials added. As far as equipment is concerned, TNMSC procures only equipment with standardisation certificates such as European CE/US FDA/equivalent Indian standards, they said.
Time of India
3 days ago
- Time of India
2,426 cr Covid fight bill hit state economy hard: Report
1 2 3 Visakhapatnam: The Covid-19 pandemic not only triggered a public health emergency but also imposed significant financial pressure on the Andhra Pradesh exchequer. Between 2019–20 and 2022–23, the state incurred an expenditure of 4,606 crore on various Covid-19 prevention and management measures, according to the CAG report. Andhra Pradesh was among the hardest-hit states, recording over 23 lakh cases—ranking fifth in the country in terms of case load. In response to the emerging crisis, the state ramped up healthcare infrastructure beginning February 2020. Key initiatives included setting up diagnostic labs, expanding testing capacity, procuring medicines and vaccines, strengthening oxygen supply networks, and mobilizing critical medical resources. Although public health is a state responsibility, the Union Ministry of Health and Family Welfare provided both technical and financial aid to assist states in managing the pandemic. The Centre introduced the Emergency Covid Response Package (ECRP) to curb transmission and mitigate impact. Under ECRP-I, funds released to Andhra Pradesh in FY 2020–21 were fully borne by the Centre. In 2021–22, the funding was shared between Centre and state in a 60:40 ratio. According to the CAG report, during the four-year period, Andhra Pradesh received a total allocation of 4,961.36 crore (both Central and state share) and spent 4,606 crore. Of this, the state govt on its part spent 2,426.47 crore. GoI's share amounted to 1,876.44 crore, of which 1,612.45 crore was utilised. From the state disaster response fund, 140.95 crore was used out of the allocated 187.87 crore. Meanwhile, 426.13 crore was spent from the district mineral fund, against an allocation of 534.41 crore. At the onset of the pandemic in Feb 2020, Andhra Pradesh had no Covid-19 testing infrastructure. The state responded swiftly by establishing 135 testing laboratories. Until these labs became operational, test samples had to be sent to other states for processing. During the second wave, the state expanded the number of Covid-19 treatment hospitals from 260 in the first wave to over 640. It also ramped up human resources, recruiting 17,300 doctors and support staff during the first wave, and an additional 18,000 medical personnel during the second wave. Notably, Andhra Pradesh became one of the few states in India to achieve 100% double-dose vaccination coverage among eligible population groups. In a major welfare initiative, Andhra Pradesh became the first state in the country to include Covid-19 treatment under its flagship Arogyasri health scheme (now renamed as NTR Vaidya Seva). This decision enabled over 1 lakh patients to receive free inpatient treatment at private hospitals across the state.
